Latest Share Purchase Plans News

Arizona Lithium has secured regulatory approval for Phase 1 production at its Prairie Lithium Project in Saskatchewan and raised $4.25 million through an oversubscribed share purchase plan, marking key milestones toward commercial lithium extraction.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

BluGlass Limited has secured its first order from the Indian Department of Defence and reported a significant 16% improvement in visible laser efficiency, alongside raising $7.6 million to support growth.

Scalare Partners has forged a strategic collaboration with Silicon Catalyst, a leading US semiconductor accelerator, while advancing its acquisition of Tank Stream Labs, a premier Australian tech coworking provider. These moves position Scalare at the forefront of deep tech support and infrastructure expansion.

S2 Resources advances exploration across multiple Australian projects with promising gold and base metal anomalies, while bolstering its balance sheet through a successful A$3.5 million capital raise.

Hawsons Iron Limited has validated a 100% dry processing circuit for its Hawsons Iron Project, securing $1.9 million in fresh capital and launching a key research collaboration with CSIRO to optimise pellet production.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

Riedel Resources Limited has progressed its Kingman Project in Arizona, securing $1.4 million in fresh capital to fund drilling and development activities at the high-grade Tintic deposit. The company also strengthened its board with the appointment of an experienced independent director.

Saturn Metals has reported a robust June quarter highlighted by significant drilling success and exceptional metallurgical recoveries at Apollo Hill, lifting its gold resource to 2.24 million ounces. These developments set the stage for a pivotal Pre-Feasibility Study and maiden Ore Reserve later this year.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.

VHM Limited has secured a crucial mining licence for its Goschen Rare Earths and Mineral Sands Project, alongside key domestic and international partnerships and a successful $8.6 million capital raise.

Iltani Resources has delivered robust drilling results at its Orient Silver-Indium Project, reinforcing its status as a leading silver-indium discovery in Australia, while securing nearly $3 million to advance exploration.